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Abstract 26
The colorectal adenoma-carcinoma sequence has provided a paradigmatic framework for 27 understanding the successive somatic genetic changes and consequent clonal expansions 28 leading to cancer. As for most cancer types, however, understanding of the earliest phases of 29 colorectal neoplastic change, which may occur in morphologically normal tissue, is 30 comparatively limited because of the difficulty of detecting somatic mutations in normal 31 cells. Each colorectal crypt is a small clone of cells derived from a single recently-existing 32 stem cell. Here, we whole genome sequenced hundreds of normal crypts from 42 individuals. 33
Signatures of multiple mutational processes were revealed, some ubiquitous and continuous, 34 others only found in some individuals, in some crypts or during some phases of the cell 35 lineage from zygote to adult cell. Likely driver mutations were present in ~1% of normal 36 colorectal crypts in middle-aged individuals, indicating that adenomas and carcinomas are 37 rare outcomes of a pervasive process of neoplastic change across morphologically normal 38 colorectal epithelium. 39 40
Introduction 41
Sequencing of >20,000 cancers has identified the repertoire of driver mutations in cancer 42 genes converting normal cells into cancer cells and revealed the mutational signatures of the 43 underlying biological processes generating somatic mutations 1,2 . Cancers are, however, end 44 stages of an evolutionary process operating within cell populations and commonly arise 45 through the accumulation of multiple driver mutations engendering a series of clonal 46 expansions. Understanding this progression has depended, in substantial part, on identifying 47 somatic mutations in morphologically abnormal neoplastic proliferations representing 48
intermediate stages between normal and cancer cells. Classical studies of driver mutations in 49 colorectal adenomas and carcinomas have been particularly influential in shaping our 50 perspective in this regard 3 . 51 52 Nine signatures (six SBS, one DBS and two ID) were present only in a subset of individuals 153 and/or a subset of crypts and are termed "sporadic". All were novel, except for SBS2, SBS13 154 and DBS8. SBS2 and SBS13 are predominantly characterised by C>T and C>G mutations at 155 TCN, are likely due to activity of APOBEC cytidine deaminases and usually occur 156 together 31, 32 . SBS2 and SBS13 were clearly observed in one colonic crypt from one 157 individual and one ileal crypt from another, but smaller contributions may be present in 158 additional crypts (Extended Data Fig. 9 ). To our knowledge, this is the first reported evidence 159 that APOBEC DNA-editing of the human genome occurs in normal cells in vivo. However, 160 in the colon at least, it is restricted to a small subset of cells. The factors that initiate it are 161 unknown, although viral entry, retrotransposon transposition and local inflammation have 162 been proposed in other contexts 33 . The wider sequence context of these mutations in normal 163 colon suggests that APOBEC3A is the major contributing enzyme 34 . 164 165 Four SBS signatures that do not match the reference set, SBSA-D, were found in normal 166 colorectal cells (SBSA has recently been reported in an oral squamous carcinoma 35 ). SBSA is 167 characterised predominantly by T>C mutations at ATA, ATT, and TTT, and T>G mutations 168 at TTT. Its mutation burden correlated closely with that of IDA, which is characterised by 169 single T deletions in short runs of Ts (with a mode of four), suggesting that they are due to 170 the same underlying mutational process. SBSA exhibited a highly variable mutational 171 burden, being present in 29/42 individuals studied, often in just a subset of crypts, and 172
showed evidence of spatial clustering in the colon, with crypts from the same biopsy carrying 173 the signature even though the mutations themselves were not shared (Supplementary Results, 174 Extended Data Fig. 9 ). 2.5-fold more T>C mutations occurred when the T was on the 175 transcribed than on the untranscribed strand. Transcriptional strand bias is often due to 176 transcription coupled nucleotide excision repair (TC-NER) acting on DNA damaged by 177 exogenous exposures causing covalently bound bulky adducts, but can also be caused by 178 transcription coupled DNA damage 36 . Assuming either is the case, damage to adenine 179 underlies SBSA. To investigate the timing of SBSA mutation generation, phylogenetic trees 180 of mutations were constructed and the mutational signatures in each branch established ( Fig.  181 3, Extended Data Fig. 6 ). SBSA was confined to early branches of these phylogenies (when 182 these were available for analysis). (Fig. 3b , Extended Data Fig. 6 f, h, z, aa, am, ao) . Using 183 the number of SBS1 mutations as indicators of real time, the mutational process underlying 184 SBSA appears to be active usually before 10 years of age. The initiating event for this 185 relatively frequent mutational process is unknown, but the results suggest an extrinsic, locally 186 acting and patchily distributed mutagenic insult occurring during childhood. 187 188 SBSB was predominantly characterised by C>T substitutions at ACA, T>A at CTN, and T>G 189 at GTG and was present in subsets of crypts from four individuals ( Fig. 3c , Extended Data 190 Fig. 6 ). In the two individuals in whom it could be timed (Extended Data Fig. 6 aa, ai) , it 191 appeared -as with SBSA -to be active in the first decade of life. SBSB correlated with 192 DBS8 and IDB (Fig. 3c , Extended Data Fig. 9 ), suggesting that they are caused by the same 193 underlying mutational process. DBS8 is composed of AC>CA and AC>CT mutations and 194 has previously been reported in rare hypermutated cancers with no obvious cause 1 . IDB is 195 dominated by deletion of a single T with no other Ts surrounding it. The mutational process 196 underlying this signature is unknown. 197 198 SBSC is characterised predominantly by one C>T mutation in CC dinucleotides. It is of 199 unknown aetiology and primarily affects three crypts from the left colon of one individual 200
with an unremarkable history (Extended Data Fig. 9 ). 201 202
All crypts from a 66 year-old man carried many thousands of mutations of SBSD, 203 characterised predominantly by T>A substitutions with a transcriptional strand bias 204 compatible with damage to adenine. This individual had been treated with multiple 205 chemotherapeutic agents (including cyclophosphamide, doxorubicin, vincristine, 206 prednisolone, chlorambucil, bleomycin and etoposide) for lymphoma and subsequently 207 developed caecal adenocarcinoma. SBSD resembles SBS25, (cosine similarity 0.9), 208 previously found in Hodgkin lymphoma cell lines from two chemotherapy-treated 209 patients 31, 37 . To our knowledge this is the first time that the mutational consequences of 210 chemotherapy have been demonstrated in normal human cells in vivo. The mutation burden 211 in this individual's colorectal epithelium was 3-5 fold higher than expected for his age, thus 212
by extrapolation equivalent to that of a 200-300 year-old, and it is plausible that other tissues 213 have been similarly affected. 214 215
Copy number changes and structural variants 216
Copy number changes and/or structural variants were found in 80 out of 449 (18%) evaluable 217 normal crypts. Five crypts exhibited eight whole chromosome copy number increases which, 218
notably, affected the same three chromosomes: 3, 7 and 9, as well as the X chromosome 219
(Extended Data Fig. 7a ). Thus, copy number increases clustered in certain crypts and tended 220
to affect certain chromosomes. No whole chromosome losses were observed. Regions of 221 copy number neutral loss of heterozygosity were observed in 12 crypts, affecting 222 chromosomes 1p, 6p, 7p, 8q, 9q, 10q (twice), 17p, 17q, 18q, 21q and 22q. Five of these copy 223
number changes could be timed and all were estimated to have occurred in adulthood. Two 224 changes that affected the same crypt appeared to be synchronous (Supplementary Results, 225 Extended Data Fig. 7b ). Forty-eight large deletions, 18 tandem duplications, four 226 translocations, and two inversions were detected. All were private to a single crypt, except for 227 one deletion which was present in two adjacent crypts sharing few mutations, indicating that 228 the deletion occurred during gestation or early childhood. 229 230
Driver mutations 231
Driver mutations are those that confer a selective advantage during cancer evolution and 232 may, but need not, promote neoplasia 38 . To search for driver mutations in normal colon, the 233 whole genome sequences of 571 crypts were supplemented with targeted sequencing of 90 234 known colorectal cancer genes in an additional series of crypts. In total, substitutions in these 235 genes were evaluable in 1,403 crypts and indels in 1,046. Statistical analysis revealed 236 evidence of positive selection on the recessive cancer genes AXIN2 (three truncating 237 mutations, adjusted q value 0.004) and STAG2 (two truncating mutations, adjusted q value 238 0.038) indicating that these mutations are likely drivers. Additional likely driver mutations 239
were identified in cancer genes characterised by canonical missense hotspot mutations. Nine 240 hotspot mutations in PIK3CA (E542K, R38H), ERBB2 (R678Q, V842I, T862A), ERBB3 241 (R475W, R667L), and FBXW7 (R505C, R658Q) were observed (Extended Data Fig. 8 ).
242
Given the specificity of these hotspot mutations, most are likely to be drivers. In addition, 243 heterozygous truncating mutations were found in the recessive cancer genes ARID2, ATM 244 (two), ATR, BRCA2, CDK12 (two), CDKN1B, RNF43 (two), TBL1XR1, and TP53 245
( Supplementary Table) . There was no statistical evidence for selection of truncating 246 mutations in the set of 90 colorectal cancer genes overall. The possibility that some have 247 conferred clonal growth advantage, however, is not excluded. No crypt carried more than one 248 putative driver mutation. 249 250 23 pairs of adjacent crypts shared over 100 SBS1 mutations and thus were likely to have been 251 generated by postnatal crypt fission. Two pairs carried driver mutations (one with an AXIN2 252 nonsense mutation and one with PIK3CA E542K), although the association of driver 253 mutations with crypt fission is not significant (p=0.17). In one sister crypt the AXIN2  254  mutation was rendered homozygous by copy number neutral chromosome 17q LOH,  255 revealing ongoing clonal evolution in normal colon ( Fig. 4, Fig. 3b ). 256 257
On the conservative assumption that just the AXIN2 and STAG2 truncating mutations and the 258 missense hotspot mutations in PIK3CA, ERBB2, ERBB3 and FBXW7 are drivers, ~1% of 259 normal colorectal crypts (~150,000 crypts) in a 50-60 year old carries a driver mutation. 260
Since in the over 70s ~40% of people have an adenoma on colonoscopy 39 and ~5% of people 261 develop colorectal cancer over their lifetime 40 (and some of these may arise from more 262 recently-acquired driver mutations) only an extremely small proportion of these crypt 263 microneoplasms becomes a macroscopically detectable adenoma (< 1/375,000) or carcinoma 264 (< 1/3,000,000) within the following few decades. 265 266
The proportion of normal colorectal cells with a driver mutation (1%) is considerably lower 267 than that observed in normal skin (30%). The lower frequency of drivers in colon may be 268 due, at least in part, to the modular structure of glandular epithelia. The small number of stem 269 cells within a crypt diminishes the probability that a cell with a driver mutation will 270 outcompete its wild-type neighbours. Moreover, even if it does colonise the crypt, a mutant 271 stem cell is entombed in it unless it can overcome the largely unknown forces that govern 272 clonal expansion through crypt fission.
274
Comparisons with colorectal cancer 275
There are marked differences between the genomes of normal colorectal stem cells and those 276 of colorectal cancers. The total mutation burdens of base substitutions (10,000-20,000) and 277 indels (1,000-2,000) found in most colorectal carcinomas 1 (excluding those with 278 hypermutator phenotypes in which it is usually >10-fold more) is higher than the ~3,000 279 substitutions and 300 indels found in most normal crypts from 50-60 year old individuals. 280
The particularly high base substitution and indel mutation burdens and associated mutational 281 signatures of DNA mismatch repair deficiency and/or polymerase epsilon/delta mutations 282
were not found in any normal colorectal crypts but are present in ~20% colorectal cancers. 283
Equally striking is the difference between the 0-4 structural changes per normal crypt (with 284 the majority having none) and the 10s to 100s per colorectal cancer 41 . In all these respects, 285
the genomes of normal crypts with driver mutations were similar to those of normal crypts 286 without drivers (Extended Data Fig. 9 ). 287 288
Elevated mutation burdens are, therefore, characteristic of the evolutionary trajectory from 289 normal colorectal cell to cancer cell. The increased base substitution and indel mutation loads 290 in cancers are due to a combination of higher burdens of the ubiquitous mutational signatures 291 found in normal crypts, additional base substitution and indel signatures thus far found 292 exclusively in cancers (confirming previous reports 5,42 ) and larger numbers of copy number 293 changes and structural variation. The earliest stages of colorectal cancer development have been revealed in this manuscript. 324
They are characterised by numerous crypts carrying driver mutations, of which only a very 325 small fraction ever manifest as macroscopic neoplasms. Certain mutated cancer genes appear 326 to foster this pervasive and invisible wave of microneoplastic change whereas others 327 particularly engender progression to colorectal adenoma and cancer. The conversion of these 328 early microneoplasms to more advanced stages of colorectal neoplasia is associated with 329 acquisition of elevated mutational loads, whether composed of base substitutions, indels, 330 structural variants or copy number changes. More extensive studies of normal colorectal 331 epithelium will enable characterisation of the rarer intermediate stages between these early 332 clones and small adenomas, and refine understanding of the development of the subset of 333 microneoplasms with higher likelihoods of becoming adenomas and carcinomas. 334 335
The proportion of normal colorectal epithelial cells with driver mutations is, however, 336
substantially lower than that of other normal tissues so far studied, notably skin 10 and 337 endometrium 11 . Colorectal epithelium is constituted of crypts, modular units which may 338 themselves constrain clonal expansion, and this architecture may contribute to such 339 differences with skin. The reason for the difference with endometrium, which is also 340 glandular, remains to be explored. 341 342
Fundamental questions are being addressed with respect to differences in cancer incidence 343 rates between tissues. The somatic mutation burden in colon and ileum is similar despite the 344 substantially higher cancer incidence rate in colon (as previously noted 4 ) and therefore does 345 not appear to account for this difference. Whether the total burden of microneoplastic change 346
across the colon and in other tissues more closely correlates with these differences is yet to be 347 determined. 348 349
Finally substitutions; on the bottom, with branch lengths proportional to the number of small 502 insertions and deletions. Scale bars are shown on the right-hand side. A stacked barplot of the 503 mutational signatures that contribute to each branch is superimposed onto every branch. 504
Please note that the ordering of signatures along a given branch is just for visualisation 505 purposes: we cannot distinguish the timing of different signatures along a branch. "X0" 506
indicates mutations that could not confidently be assigned to any signature. The phylogenies 507
for all individuals are shown in Extended Data Fig. 6 . (a) a phylogeny dominated by 508 ubiquitous and known signatures. A PIK3CA mutation is shared by two crypts. (b) a 509 phylogeny with a strong contribution of SBSA and IDA, as well as an AXIN2 mutation (the 510 same as in Fig. 4 ). (c) a phylogeny with SBSB, DBS8, and IDB. (d) the phylogeny of the 511 individual exposed to chemotherapy, showing a strong contribution of SBSD. 512 513 Figure 4 . An AXIN2 driver mutation in normal colon. (a) a section (after dissection) in 514
which an inactivating AXIN2 mutation was found. Red dots represent crypts with the AXIN2 515 mutation. Blue dots represent crypts that could be assessed and were found not to have the 516 mutation. Crypts without dots failed sequencing and could not be assessed. (b) the two crypts 517
with the AXIN2 mutations prior to dissection did not appear different to other crypts. (c) copy 518 neutral loss of heterozygosity (CNN-LOH) of one of the crypts over the AXIN2 locus. The 519 copy number state (y axis) for every chromosome is shown, with one allele coloured red and 520 the other green. (d) Jbrowse image of reads supporting the AXIN2 mutations in each of the 521 crypts. The mutation is coloured red. 25 out of 29 reads support the mutation in the crypt that 522 has CNN-LOH; the four reads that do not are presumably the result of stromal contamination. crypts. For all crypts that were whole genome sequenced to sufficient depth and for crypts 595 that underwent targeted sequencing and in which driver mutations were found, the signatures 596 and driver mutations are shown. Each vertical column represents a crypt. The individual to 597 which each crypt belongs is indicated by alternating colours in the top bar. The site to which 598 each crypt belongs is shown underneath. The contribution of each signature to each crypt; 599 thus the crypt with the largest contribution of a given signature is coloured purple, and the 600 crypt with the smallest contribution is coloured white. Crypts in which the signatures could 601 not be assessed, either because they underwent targeted sequencing or the coverage was poor, 602 are coloured grey. Driver mutations, including heterozygous mutations in tumour suppressor 603 genes, are indicated by a black bar. 604 605 606 607 SUPPLEMENTARY METHODS 608 609
Human tissues 610
We obtained healthy colonic biopsies from four cohorts. The first represents seven deceased 611 organ donors ranging in age from 36 to 67, from whom colonic and small intestinal biopsies 612
were taken at the time of organ donation (REC 15/EE/0152). The second represents 613
individuals aged 60 to 72 who were having a colonoscopy following a positive faecal occult 614 blood test as part of the Bowel Cancer Screening Programme (Ethical approval 08-H0308-615 13); we selected 16 who were not found to have either an adenoma or a carcinoma on 616 colonoscopy, and 15 who were found to have a colorectal carcinoma (the normal biopsies 617 that we use were distant from these lesions). The third cohort represents three paediatric 618 patients who underwent routine colonoscopy to exclude inflammatory bowel disease and who 619
were found to have a completely normal intestinal mucosa macroscopically and histologically 620
(REC 12/EE/0482). The final cohort included one 78 year-old gentleman with oesophageal 621 cancer who underwent a warm autopsy (REC 13/EE/0043). All samples were obtained with 622 informed consent and studies approved by East of England Research Ethics Committees. 623 624
Laser capture microdissection of colonic crypts 625
Fresh frozen biopsies were embedded in optimal cutting temperature (OCT) compound. 30 626 micrometre sections were fixed in methanol for five minutes, washed three times with 627 phosphate-buffered saline, and stained with Gill's haematoxylin for 20 seconds. Crypts were 628 isolated by laser capture microdissection, and collected in separate wells of a 96-well plate. 629
They were lysed using the Arcturus PicoPure Kit (Applied Biosystems) according to the 630 manufacturer's instructions. DNA library prep then proceeded without clean-up or 631 quantification. 632 633
Library preparation 634
Two library preparation methods were used for laser capture microdissected (LCM) material: 635
in initial experiments sonication was used to fragment DNA, and later, an enzymatic 636 fragmentation method was implemented as it could make libraries from even lower input. 637
Comparison of the two methods showed no difference in mutation calls once post-processing 638 filters (described below) had been implemented. All samples in this study were processed 639 using an Agilent Bravo Workstation (Option B; Agilent Technologies the probability of all possible genotypes at each nucleotide. CaVEMan copy number options 730
were set to major copy number 5 and minor copy number 2 for normal clones, as in our 731 experience this maximises sensitivity. The algorithm was run using an unmatched normal in 732 order to be able to derive phylogenies: had another sample from the same individual been 733 treated as a matched normal, early embryonic mutations would have been treated as germline 734
and discarded, resulting in incorrect trees. 735 736
Second, a number of post-processing filters were applied. These included filtering against a 737 panel of 75 unmatched normal samples to remove common single nucleotide polymorphisms, 738 post-processing as described previously 32 and two filters (only applied to whole genome 739 sequencing data) designed to remove mapping artefacts associated with BWA-MEM: the 740 median alignment score of reads supporting a mutation should be greater than or equal to 741 140, and fewer than half of these reads should be clipped. The library preparation protocol for 742 microbiopsies produced shorter library insert sizes than standard methods. Reads could 743 therefore overlap, resulting in double counting of mutant reads. Fragment-based statistics 744
were generated to prevent the calling of variant supported by a low number of fragments. 745
Variants were annotated by ANNOVAR 47 and fragment-based statistics (fragment coverage, 746 number of fragments supporting the variant, fragment-based allele fraction) were calculated 747 for each variant after the exclusion of marked PCR duplicates. In the rare event of 748 discordance in the called base at the variant position between overlapping paired-end reads, 749 the base with the highest quality score was selected. Fragment-based statistics were 750 calculated separately for high quality fragments (alignment score ≥ 40 and base scores ≥ 30). 751
Variants supported by at least three high quality fragments were retained and used for the 752 next stage of variant filtering. Inspection of variants specific to LCM experiments revealed 753 that the vast majority were present within inverted repeats capable of forming hairpin 754 structures, that they were supported by reads with very similar alignment start position (and 755 so not marked as PCR duplicates), and were primarily located close to the alignment start 756
within the supporting reads. Commonly these variants coincided with other proximal variants 757
(1-30 bp), but filtering based on variant proximity would also remove actual kataegis events. 758
In silico modelling of the potential hairpin showed that the variants were aligning to each 759 other in the stem of the structure, but could not form a base pair, while all other bases could. 760
The artefacts are likely the consequence of erroneous processing of cruciform DNA (existing 761 either prior to DNA isolation or formed during library preparation) by the enzymatic 762 digestion protocol applied. We have considered modelling the hairpin structures to filter these 763 variants, but given the fact that read clustering (i.e., similar alignment position) serves as a 764 hallmark for these artefacts, we opted to use the proximity of the variant to the alignment 765 start, and the standard deviation (SD) and median absolute deviation (MAD) of the variant 766 position within the supporting reads, as features for filtering. These statistics were calculated 767 separately for positive and negative strand aligned reads. In case the variant was supported by 768 a low number of reads (i.e., 0-1 reads) for one of the strands, the filtering was based only on 769
the statistics generated for the other strand. Per variant, if one of the strands had too few reads 770 supporting, it was required for the other strand that either: (I) there should be ≤ 90% 771 supporting reads to report the variant within the first 15% of the read starting from the 772 alignment start, or (II) the statistics MAD > 0 and SD > 4. Per variant, if both strands were 773
supported by sufficient reads it was required for both strands separately that either: (I) there  774 should be ≤ 90% supporting reads to report the variant within the first 15% of the read, (II) 775 the statistics MAD > 2 and a SD > 2, or (III) that the other strand should have the statistics 776 MAD > 1 and SD > 10 (i.e., the variant is retained if the other strand demonstrates strong 777 measures of variance). In our experience, the proposed strategy vastly reduces the number of 778
artefactual variants while retaining all other variants, as assessed by running the last filtering 779 step on WGS data from non-LCM experiments. 780 781
Third, mutations were genotyped in every sample. A pileup of all the samples from a given 782 individual was constructed, counting the number of mutant and wild type reads in every 783 sample over every site that had been called in any sample from that person. Only reads with a 784 mapping quality of 30 or above and bases with a base quality of 30 or above were counted. 785
After applying these filters, mutations were genotyped based on the number of mutant and 786 wild type reads at each locus. Mutations were called based on a variant allele fraction (VAF) 787 > 0.2, a depth > 7, and at least 4 mutant reads. If the depth over a locus was less than seven in 788 a given sample, or if there was more than one mutant read but the other criteria were not met, 789
the genotype was set to NA for tree construction purposes. Loci that were set to NA in more 790 than one third of the samples were removed for construction of the phylogeny. Positions were 791 called as germline if they were either called as present or NA in all of the samples from a 792
given individual. 793 794 795 796
Calling short insertions and deletions (indels) 797
As for substitutions, calling of indels was broken down into mutation discovery, filtering, and 798
genotyping. Mutations were called with the Pindel algorithm 48 using an unmatched normal. 799
Post processing filters were applied as in , and the number of mutant and 800 wild-type reads was tabulated as above. The same dataset-specific filters were applied as for 801
substitutions. Indels were then genotyped based on a VAF>0.2, a depth of at least 10, and 802 support of at least 5 mutant reads. 803 804
Calling structural variants 805
Genomic rearrangements were called using the BRASS algorithm 41 806
(https://github.com/cancerit/BRASS). Abnormally paired read pairs from WGS were grouped 807 and filtered by read remapping. Read pair clusters with ≥50% of the reads mapping to 808 microbial sequences were removed, as were rearrangements where the breakpoint could not 809 be reassembled. Candidate breakpoints were matched to copy number breakpoints defined by 810
ASCAT (see below) within 10kb. Only structural variants where the two breakpoints were 811 more than 1000 base pairs apart were considered. Structural variants were called against a 812 matched normal skin or blood sample when available and against another crypt from the 813 same individual with good coverage when not. 814 815
Calling copy number 816
Copy number changes were called using the Allele-Specific Copy number Analysis of 817
Tumours (ASCAT) algorithm 49 . The same matched normal sample was used as for calling 818 structural variants. For additional validation of copy number changes in normal colon, the 819
QDNAseq algorithm 50 was run. ASCAT uses both the read depth and ratios of heterozygous 820 single nucleotide polymorphisms to determine an allele-specific copy number, while the 821
QDNAseq relies solely on variations in sequencing coverage. To call amplifications and 822 deletions in the colonic microbiopsy cohort, only those that were both called by ASCAT and 823 showed a clear departure from the background log2ratio by QDNAseq were retained. To call 824 copy neutral loss of heterozygosity in this cohort, all such events called by ASCAT were 825 checked visually on Jbrowse 51 to verify an imbalance of parental snps. Only crypts with 826 >10X coverage, for which copy number changes could be reliably detected, were used. 827 828
Detection of driver variants and positive selection 829
Driver mutations were detected both through an unbiased dNdS method and through manual 830 annotation. For these analyses, the CaVEMan and Pindel calls were used without post-831 processing filters in order to maximise our sensitivity. All putative driver variants were 832 visually inspected using Jbrowse 51 , and so we could afford a higher false positive rate in the 833 mutation discovery phase. 834 835 dNdScv 52 was used to conduct three tests: first, using only the whole genome sequencing 836
data, an analysis of selection over all genes; second, using combined whole genome and 837 targeted sequencing data, over all the genes covered by the bait-set; and finally, using again 838 a  t  i  o  n  s  c  a  l  l  e  d  a  g  a  i  n  s  t  u  n  m  a  t  c  h  e  d  n  o  r  m  a  l  w  i  t  h  C  a  V  E  M  a  n  a  l  g  o  r  i  t  h  m   F  i  l  t  e  r  e  d  a  g  a  i  n  s  t  7  5  u  n  m  a  t  c  h  e  d  n  o  r  m  a  l  s   P  o  s  t  p  r  o  c  e  s  s  i  n  g  f  i  l  t  e  r  s  a  s  d  e  s  c  r  i  b  e  d  i  n  N  i  k  -Z  a  i  n  a  l  e  t  a  l  2  0  1  2   M  e  d  i  a  n  a  l  i  g  n  m  e  n  t  s  c  o  r  e  o  f  r  e  a  d  s  (  A  S  M  D  )  >  =  1  4  0   F  e  w  e  r  t  h  a  n  h  a  l  f  t  h  e  r  e  a  d  s  s  h  o  u  l  d  b  e  c  l  i  p  p  e  d  (  C  L  P  M  =  0  )   F  r  a  g  m  e  n  t  b  a  s  e  d  a  n  d  c  r  u  c  i  f  o  r  m  f  i  l  t  e  r  s   P  i  l  e  u  p  :  c  o  u  n  t  m  t  a  n  d  w  t  r  e  a  d  s  i  n  a  l  l  s  a  m  p  l  e  s  f  o  r  s  u  b  s  c  a  l  l  e  d  i  n  a  n  y  s  a  m  p  l  e this combined dataset, over 90 selected cancer genes (appendix). R code for this analysis is 839 included in the supplementary information. 840 841
Manual annotation of driver variants based on prior knowledge complemented this. A list of 842 90 colorectal cancer genes (appendix) curated from the literature that were also covered by 843 the bait-set were intersected with the list of substitutions and indels from combined whole 844 genome and targeted sequencing. Mutations were annotated as putative drivers if they were 845 either missense mutations that fell in an oncogene hotspot (based on visualisation of the 846 distribution of mutations in the gene on COSMIC 53 ), or if they were truncating mutations that 847 fell in a tumour suppressor gene. 848 849
Structural variants that might act as drivers were assessed by intersection of genes involved 850
in each structural variant with the twelve genes involved in gene fusions that have been 851 reported in colorectal cancer in COSMIC (VTI1A, TCF7L2, TPM3, NTRK1, PTPRK, RSPO3, 852 ETV6, NTRK3, EIF3E, RSPO2, C2orf44, and ALK). No fusion genes were found. None of the 853 genes involved in structural variants in our data overlapped with the list of 90 cancer genes 854 used for assessing substitutions and indels, and nor were there any genes that were affected 855 by more than one structural variant. No high-level copy number amplifications were observed 856 and there were no homozygous deletions. 857 858
Estimation of frequency of driver mutations in cancer 859
Publically-available colorectal cancer mutation calls were obtained from The Cancer Atlas 860
Network 43 . Driver mutations were annotated manually in the same way as in our dataset: only 861 mutations that fell in the 90 genes that we had selected were considered, and they were 862 annotated as putative drivers if they were either missense mutations that fell in an oncogene 863 hotspot (based on visualisation of the distribution of mutations in the gene on COSMIC 53 ), or 864
if they were truncating mutations that fell in a tumour suppressor gene. 865 866
Construction of phylogenies 867
Phylogenies are used in this analysis for timing mutations. The most informative branches in 868 this case are the long branches shared by a small number of crypts, which are very robust to 869 all tree construction methods. Trees were built using maximum parsimony using substitutions 870 called as described above. For every individual, the input matrix of mutation calls was 871 bootstrapped 100 times. Phylogenies were constructed for each replicate using the Wagner 872 method of the Mix programme from the Phylip suite of tools 54 . The consensus of all the 873 phylogenies constructed was used. 874 875
The phylogenies were validated using the indel calls. To do this, the same procedure as for 876 substitutions was followed for indel matrices. As there were fewer indels than substitutions, 877 nodes in indel phylogenies were generally reconstructed with lower confidence than in 878 substitution phylogenies, but they broadly agree. 85% of nodes reconstructed with >=90% 879 confidence in the indel tree were present with exactly the same set of descendants in the 880 substitution trees. 881 882
The phylogeny inference programme used provided the topology of the tree but not the 883 assignment of mutations. Mutations from the input matrix of genotypes therefore have to be 884
re-assigned to branches. In order to assign a set of mutation calls with no false negative and 885 no false positives to a tree, each branch of the tree was considered in turn. If a mutation was 886 called in all the descendants of a given branch, and in no samples that were not descendants 887 of the branch, mutations were assigned to that branch. 888 889 Some colonic microbiopsies suffered from low coverage and stromal contamination. For this 890 reason, we did not expect mutations to fit the tree perfectly, as a mutation that was truly 891 present in a colony might be missed if too few supporting reads are found. Mutations were 892 only assigned to the tree in order to determine the mutational processes active at a particular 893 time. We reasoned that it was preferable to assign only mutations that fit the tree perfectly 894 and adjust the branch lengths based on the power to call mutations at a given branch, rather 895 than attempting to assign mutations that fit the tree imperfectly. Using the clonality and 896 coverage of all descendants of a branch, the proportion of true substitutions or indels on the 897 branch that would be first discovered (whether by CaVEMan or Pindel) and then genotyped 898
as present according to the criteria described above was calculated. The observed branch 899 length was then adjusted by dividing by this proportion. This was done for both substitutions 900 and indels, but not for structural variants and for larger copy number changes due to a lack of 901
data: most branches have no large variants and so could not be extended appropriately. 902
Rearrangements and copy number changes were assigned to phylogenies manually. 903 904
Extraction of mutational signatures 905
Mutational signatures were extracted using the mutations assigned to every branch of a 906 phylogeny as a 'sample'. This allows better discrimination of mutational processes that may 907 occur at different times within the same cell. Mutations were categorised following the 908 method used by the Mutational Signatures working group of the Pan Cancer Analysis of 909
Whole Genomes (PCAWG) 1 . Single base substitutions were categorised into 96 classes 910 according the identity of the pyrimidine mutated base pair, and the base 5' and 3' to it. 911 Doublet base substitutions were categorised into 78 classes according to the identity of the 912 reference and alternative bases. Indels were classified according to whether they were an 913 insertion or a deletion, the identity of the inserted/deleted base, the length of the 914 mononucleotide tract in which they occurred, or the degree of homology with the 915 surrounding sequence into 83 classes (Fig. 1a ). 916 917
Signatures were extracted using a hierarchical Dirichlet Process 55,56 . Code and the input 918 mutations are provided at https://github.com/HLee-Six/colon_microbiopsies. First, the 919 algorithm was conditioned on the set of mutational signatures that have found to be operative 920 in colorectal cancers in PCAWG 1 : SBS1, SBS2, SBS3, SBS5, SBS13, SBS16, SBS17a, 921
SBS17b, SBS18, SBS25 (included although it is not found in colorectal cancer because the 922 similarity with the mutational profile with crypts from one individual had been previously 923 noted), SBS28, SBS30, SBS37, SBS40, SBS41, SBS43, SBS45, SBS49, DBS, DBS3, DBS4, 924 DBS6, DBS7, DBS8, DBS9, DBS10, DBS11, ID1, ID2, ID3, ID4, ID5, ID6, ID7, ID8, ID10, 925 and ID14. This allows simultaneous discovery of new signatures and matching to known 926 ones. Nine single base substitution (SBS), two doublet base substitution (DBS), and five 927 indel (ID) signatures were discovered (Extended Data Fig. 2) . Despite pre-conditioning, 928
signatures that were perfectly correlated in all samples were still amalgamated. This 929 occurred, for example, with signatures 1, 5, and 18. Therefore, expectation maximisation was 930 used to deconvolute all HDP signatures into known PCAWG signatures. If a signature 931 reconstituted from the components that expectation maximisation extracted (only including 932 PCAWG signatures that accounted for at least 10% of mutations in each sample to avoid 933 over-fitting) had a cosine similarity to the HDP signature of more than 0.95, the signature 934 was presented as its expectation maximisation deconvolution. Three HDP signatures met 935 these criteria: the HDP SBS1 signature was deconvoluted into a mixture of PCAWG SBS1, 936 PCAWG SBS5, and PCAWG SBS18; the HDP DBSA was deconvoluted in PCAWG DBS2, 937 PCAWG DBS4, PCAWG DBS6, PCAWG DBS9, and PCAWG DBS11; and the HDP IDC 938 was deconvoluted into PCAWG ID1, PCAWG ID2, and PCAWG ID5 (Extended Data Fig.  939 3). To test the robustness of this signature analysis, other signature extraction methods were 940 used: HDP with no pre-conditioning, the non-negative matrix factorisation (NNMF) method 941 used by Blokzijl and colleagues 4 , and a version of the NNMF algorithm used by Alexandrov 942 and colleagues 1 . These all produced comparable results (Extended Data fig. 4 AC>CA  AC>CG  AC>CT  AC>GA  AC>GG  AC>GT  AC>TA  AC>TG  AC>TT  AT>CA  AT>CC  AT>CG  AT>GA  AT>GC  AT>TA  CC>AA  CC>AG  CC>AT  CC>GA  CC>GG  CC>GT  CC>TA  CC>TG  CC>TT  CG>AT  CG>GC  CG>GT  CG>TA  CG>TC  CG>TT  CT>AA  CT>AC  CT>AG  CT>GA  CT>GC  CT>GG  CT>TA  CT>TC  CT>TG  GC>AA  GC>AG  GC>AT  GC>CA  GC>CG  GC>TA  TA>AT  TA>CG  TA>CT  TA>GC  TA>GG  TA>GT  TC>AA  TC>AG  TC>AT  TC>CA  TC>CG  TC>CT  TC>GA  TC>GG  TC>GT  TG>AA  TG>AC  TG>AT  TG>CA  TG>CC  TG>CT  TG>GA  TG>GC  TG>GT  TT>AA  TT>AC  TT>AG  TT>CA  TT>CC  TT>CG  TT>GA  TT>GC 
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